These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 708018)

  • 21. Netilmicin use in pediatric patients.
    Chindasilpa V; Schauf V; Hamilton LR; Riff LJ
    Dev Pharmacol Ther; 1980; 1(4):238-53. PubMed ID: 7438970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of single or multiple doses of gentamicin and netilmicin on their cortical, medullary, and papillary distribution.
    Bergeron MG; Trottier S
    Antimicrob Agents Chemother; 1979 May; 15(5):635-41. PubMed ID: 525979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical pharmacology of netilmicin in preterm and term newborn infants.
    Granati B; Assael BM; Chung M; Montini C; Parini R; Pollazzon P; Gagliardi L; Radwanski E; Rubaltelli FF
    J Pediatr; 1985 Apr; 106(4):664-9. PubMed ID: 3981323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological variability of multiple dose pharmacokinetics of netilmicin in man.
    Blaser J; Rieder H; Niederer P; Lüthy R
    Eur J Clin Pharmacol; 1983; 24(3):399-406. PubMed ID: 6861854
    [No Abstract]   [Full Text] [Related]  

  • 25. Distribution kinetics of netilmicin in human blister fluid: effect of renal impairment.
    Lanao JM; López A; Domínguez-Gil A; Martin J; Gómez JR; Tabernero JM
    Biopharm Drug Dispos; 1991 Mar; 12(2):149-62. PubMed ID: 2031996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Penetration of netilmicin into respiratory secretions].
    Bergogne-Berezin E; Berthelot G; Even P; Safran D
    Presse Med; 1983 Feb; 12(5):287-92. PubMed ID: 6220386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Netilmicin pharmacokinetics after single intravenous doses to elderly male patients.
    Welling PG; Baumueller A; Lau CC; Madsen PO
    Antimicrob Agents Chemother; 1977 Sep; 12(3):328-34. PubMed ID: 907325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis.
    Reitberg DP; Marble DA; Schultz RW; Whall TJ; Schentag JJ
    Antimicrob Agents Chemother; 1988 Apr; 32(4):503-9. PubMed ID: 3377461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of endotoxin on the intrarenal distribution of gentamicin, netilmicin, tobramycin, amikacin, and cephalothin.
    Bergeron MG; Bergeron Y
    Antimicrob Agents Chemother; 1986 Jan; 29(1):7-12. PubMed ID: 3524424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of aminoglycosides in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Oksenhendler G; Fillastre JP
    Antibiot Chemother (1971); 1978; 25():163-80. PubMed ID: 352252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Absorption, excretion and metabolism of netilmicin in beagle dogs (author's transl)].
    Tokiwa T; Ohashi H
    Jpn J Antibiot; 1982 Apr; 35(4):987-92. PubMed ID: 7097993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aminoglycoside redistribution phenomenon after hemodialysis: netilmicin and tobramycin.
    Halstenson CE; Berkseth RO; Mann HJ; Matzke GR
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):50-5. PubMed ID: 3557729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction.
    Bolton WK; Scheld WM; Spyker DA; Overby TL; Sande MA
    Antimicrob Agents Chemother; 1980 Dec; 18(6):933-8. PubMed ID: 6453555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function.
    Aweeka F; Jayesekara D; Horton M; Swan S; Lambrecht L; Wilner KD; Sherwood J; Anziano RJ; Smolarek TA; Turncliff RZ
    Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):27S-33S. PubMed ID: 10771451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mezlocillin pharmacokinetics in renal impairment.
    Aronoff GR; Sloan RS; Luft FC; Nelson RL; Maxwell DR; Kleit SA
    Clin Pharmacol Ther; 1980 Oct; 28(4):523-8. PubMed ID: 6447570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal pharmacology of netilmicin.
    Chiu PJ; Miller GH; Brown AD; Long JF; Waitz JA
    Antimicrob Agents Chemother; 1977 May; 11(5):821-5. PubMed ID: 879737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Netilmicin therapy of serious renal and urinary tract infections in patients with normal and impaired renal function.
    Denneberg T; Haeger K; Juhlin I
    Scand J Infect Dis Suppl; 1980; Suppl 23():135-40. PubMed ID: 6937958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Absorption, distribution, metabolism and excretion of netilmicin in rats (III). Metabolic fate of 14C-netilmicin after intramuscular administration (author's transl)].
    Uda F; Fujino A; Tokiwa T
    Jpn J Antibiot; 1982 Apr; 35(4):967-78. PubMed ID: 7097991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of tocainide in patients with renal dysfunction and during haemodialysis.
    Wiegers U; Hanrath P; Kuck KH; Pottage A; Graffner C; Augustin J; Runge M
    Eur J Clin Pharmacol; 1983; 24(4):503-7. PubMed ID: 6407848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gentamicin disposition in young and elderly patients with various degrees of renal function.
    Matzke GR; Jameson JJ; Halstenson CE
    J Clin Pharmacol; 1987 Mar; 27(3):216-20. PubMed ID: 3680577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.